systematic_review
    2016

    Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis

    Novara G, Giannarini G, Alcaraz A, Cozar-Olmo JM, Descazeaud A, Montorsi F, Ficarra V

    Published in European Urology Focus

    Key Findings

    Hexanic extract reduced IPSS and nocturia versus placebo with a low rate of sexual adverse events compared with alpha-blockers and 5-ARIs.

    Conclusions

    Preparation matters when interpreting conflicting saw palmetto evidence.

    Limitations

    Industry involvement; limited number of high quality trials.

    Supplements Studied

    Hexanic extract reduced IPSS and nocturia versus placebo with a low rate of sexual adverse events.

    Outcomes Measured

    Prostate Size Reduction

    Hexanic extract reduced IPSS and nocturia versus placebo.

    Study Details

    Year:2016
    00
    Quality Score:6/10

    Access Study

    View on DOIOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.